What is Resonant Therapeutics worth?
$17.3Mlast known valuation
Resonant Therapeutics last raised $2.5M in its Seed Round (Oct 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Resonant Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2021 | Seed Round | $2.5M | ▮ | ▮ |
How Resonant Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Resonant Therapeutics, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Resonant Therapeutics worth?
- Resonant Therapeutics's implied valuation is $17.3M, based on the PA Mark composite price of about $10 per share as of Sep 2026.
- How much has Resonant Therapeutics raised?
- Resonant Therapeutics has raised $6.1M in total funding across 1 recorded rounds.
- When did Resonant Therapeutics last raise?
- Resonant Therapeutics last raised in Oct 2021 (Seed Round), raising $2.5M.